All Stories

  1. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  2. The need to promote smell health across the globe
  3. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  4. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  5. The need to promote smell health across the globe
  6. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  7. Gustatory dysfunction in dementia and cognitive decline
  8. Olfactory loss and dysfunction in dementia and cognitive decline
  9. A New Approach to Dementia
  10. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  11. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  12. Epidemiology of Cholesteatoma in the UK Biobank
  13. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  14. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  15. Epidemiology of Cholesteatoma in the UK Biobank
  16. Smell Above All: Envisioning Smell-Centred Future Worlds
  17. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  18. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  19. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  20. Obesity and Olfaction
  21. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  22. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  23. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  24. Delivery of Topical Drugs to the Olfactory Cleft
  25. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  26. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  27. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  28. Position paper on olfactory dysfunction: 2023
  29. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  30. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  31. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  32. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  33. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  34. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  35. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  36. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  37. Nose Gym: An Interactive Smell Training Solution
  38. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  39. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  40. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  41. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  42. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  43. The Nose and the Effects of SARS-CoV-2 Pandemic
  44. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  45. The EUFOREA pocket guide for chronic rhinosinusitis
  46. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  47. Investigations and Outcomes for Olfactory Disorders
  48. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  49. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  50. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  51. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  52. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  53. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  54. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  55. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  56. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  57. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  58. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  59. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  60. International consensus statement on allergy and rhinology: Olfaction
  61. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  62. Interventions for the treatment of persistent post-viral olfactory dysfunction
  63. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  64. Olfaction and CSF Leak
  65. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  66. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  67. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  68. Barriers to effective health care for patients who have smell or taste disorders
  69. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  70. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  71. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  72. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  73. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  74. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  75. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  76. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  77. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  78. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  79. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  80. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  81. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  82. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  83. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  84. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  85. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  86. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  87. Patient Experiences of Postinfectious Olfactory Dysfunction
  88. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  89. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  90. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  91. Comparison of COVID-19 and common cold chemosensory dysfunction
  92. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  93. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  94. Patient Experiences of Post-Infectious Olfactory Dysfunction
  95. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  96. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  97. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  98. Olfactory Loss of Function as a Possible Symptom of COVID-19
  99. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  100. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  101. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  102. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  103. Qualitative Olfactory Disorders: Patient experiences and self-management
  104. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  105. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  106. Parosmia is associated with relevant olfactory recovery after olfactory training
  107. The impact of patients losing their sense of smell
  108. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  109. Cholesteatoma and family history: An international survey
  110. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  111. Biologics for chronic rhinosinusitis
  112. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  113. Biologics for chronic rhinosinusitis
  114. An unmet need: Patients with smell and taste disorders
  115. 139 Risk of parkinson’s in idiopathic anosmia
  116. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  117. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  118. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  119. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  120. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  121. What is the most appropriate treatment for chronic rhinosinusitis?
  122. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  123. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  124. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  125. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  126. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  127. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  128. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  129. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  130. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  131. Wooden spatula sinusitis following maxillary expansion surgery
  132. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  133. Topical and systemic antifungal therapy for chronic rhinosinusitis
  134. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  135. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  136. Saline irrigation for allergic rhinitis
  137. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  138. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  139. Endonasal Approaches to Maxillary Sinus
  140. The use of nasal sprays and rinses in patients with chronic sinus disease
  141. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  142. Initial assessment in the management of adult epistaxis: systematic review
  143. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  144. Health care usage and quality of life reporting in chronic sinusitis patients
  145. The genetics of cholesteatoma. A systematic review using narrative synthesis
  146. Position paper on olfactory dysfunction
  147. Chronic rhinosinusitis and mood disturbance
  148. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  149. Saline irrigation for allergic rhinitis
  150. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  151. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  152. Position paper on olfactory dysfunction
  153. Chronic rhinosinusitis and mood disturbance
  154. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  155. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  156. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  157. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  158. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  159. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  160. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  161. Topical and systemic antifungal therapy for chronic rhinosinusitis
  162. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  163. SNOT-22 in a control population
  164. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  165. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  166. Genetics of Cholesteatoma Project
  167. Short-course oral steroids alone for chronic rhinosinusitis
  168. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  169. Different types of intranasal steroids for chronic rhinosinusitis
  170. Systemic and topical antibiotics for chronic rhinosinusitis
  171. Saline irrigation for chronic rhinosinusitis
  172. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  173. Chronic rhinosinusitis and mood disturbance
  174. Long term quality of life in patients with fungal sinus disease
  175. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  176. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  177. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  178. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  179. Systemic and topical antibiotics for chronic rhinosinusitis
  180. Saline irrigation for chronic rhinosinusitis
  181. Different types of intranasal steroids for chronic rhinosinusitis
  182. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  183. Short-course oral steroids alone for chronic rhinosinusitis
  184. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  185. The impact of commissioning for rhinosinusitis in England
  186. Investigation of nasal diseases
  187. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  188. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  189. Authors’ response
  190. Hyposmia
  191. Assessing the sense of smell
  192. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  193. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  194. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  195. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  196. The Impact of Olfactory Disorders in the United Kingdom
  197. Chronic Rhinosinusitis and Mood Disturbance
  198. Management of CRSwNPs Surgically
  199. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  200. SNOT-22 in a Control Population
  201. Anatomy and Physiology of the Olfactory and Gustatory Systems
  202. Cerebrospinal Fluid Rhinorrhoea
  203. Ciliary Motility Disorders
  204. Clinical Governance and Audit
  205. Complications of Sinusitis
  206. Endoscopic Sinus Surgery and Complications
  207. Epistaxis
  208. European Position Paper on Rhinosinusitis and Nasal Polyps
  209. Facial Flaps, Scars, and Keloids
  210. Facial Fractures and Swelling
  211. Fungal Sinus Disease
  212. Headache and Facial Pain
  213. Medical Statistics
  214. Microbiology of ENT
  215. Olfactory and Gustatory Disorders
  216. Sinonasal Anatomy and Physiology
  217. Tumours of the Nose and Paranasal Sinuses
  218. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  219. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  220. Unilateral cacosmia: a presentation of maxillary fungal infestation
  221. When mealtime is the most dreaded moment of your day
  222. Pneumatisation of turbinates and paranasal sinuses in children: case report
  223. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  224. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  225. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  226. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  227. A useful tool - systematic checklist for evaluating sinus scans
  228. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  229. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  230. Allergic fungal rhinosinusitis - a new staging system
  231. Allergic fungal rhinosinusitis - a new staging system
  232. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  233. Selecting the Best Approach to the Frontal Sinus
  234. Nanomedicine in otorhinolaryngology: what does the future hold?
  235. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  236. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  237. Tumefactive fibroinflammatory lesion of the frontal sinus
  238. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  239. SUBJECTS AND METHODS
  240. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  241. Proximal Lacrimal Obstruction – A Review
  242. The superosmic phenomenon
  243. The Leicester Olfactometer
  244. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  245. ENT cases seen at a local ‘walk-in centre’: a one year review
  246. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  247. A brief history of olfaction and olfactometry
  248. The superosmic phenomenon
  249. Olfactory clearance: what time is needed in clinical practice?
  250. The Effect of Female Hormone Manipulation on Nasal Physiology
  251. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  252. R152: Olfactory Adaptation and Clearance in Clinical Practice
  253. Bronchiectasis and sino-nasal disease: a review
  254. What is the short term effect of perfumes on olfactory thresholds?
  255. Which variables matter in smell tests in the clinic?
  256. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  257. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  258. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  259. Comparison of Subjective Perception with Objective Measurement of Olfaction
  260. Response to Rachmanidou
  261. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  262. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  263. Do our Noses Lead Us Away from the Scent?
  264. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  265. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  266. Is there a role for more day-case septal surgery?
  267. Erratum
  268. Canalicular adenoma of the parotid gland
  269. Paediatric retropharyngeal abscess
  270. Which solvent for olfactory testing?
  271. Nasal physiological changes during pregnancy
  272. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  273. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  274. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  275. Subjects and methods
  276. Hyposmia